RVRC · Revium Rx. · Executive Compensation
$1.43
At close · Sep 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$86.84M
Shares
60.73M
Volume · Sep 7
248
Avg daily vol (2 sessions)
248
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Inna Martin | President | Resigned | 2026-06-22 |
| Inna Martin | Chief Operating Officer | Resigned | 2026-06-22 |
| Inna Martin | member of the Board of Directors | Resigned | 2026-06-22 |
| Igor Bluvstein | Chief Financial Officer | Appointed | 2026-06-01 |
| Arie Gordashnikov | Chief Financial Officer | Resigned | 2026-06-01 |
| Shlomi Schwartzblat | Director | Appointed | 2026-04-20 |
| Shlomi Schwartzblat | Chairman of the Board | Appointed | 2026-04-20 |
| Amir Avraham | permanent Chief Executive Officer | Appointed | 2026-04-20 |
Leadership
- Amir Avraham CEO
- Shlomi Schwartzblat Chairman, Board Member
- Igor Bluvstein CFO